Category: Pharma Industry News
Biocon ties-up with Tabuk to bring specialty generic products in Middle East
Indian pharma company Biocon Limited has forged a partnership with Tabuk Pharmaceutical Manufacturing Company to commercialize certain specialty generic medicines in the Middle East. Tabuk ... Read More
Morepen Laboratories secures FDA approval for Fexofinadine (Allegra)
Morepen Laboratories Limited has secured approval from the US Food and Drug Administration (FDA) for its anti-allergy drug Fexofinadine Hydrochloride, which it expects to begin ... Read More
Sun Pharma Advanced Research signs licensing deal with Biomodifying
Sun Pharma Advanced Research Company (SPARC) has signed an agreement with US-based Biomodifying for the exclusive licensing of the latter’s intellectual property (IP), including all ... Read More
Lupin signs agreement for biosimilar Pegfilgrastim in Brazil
Lupin Limited has signed an exclusive distribution and marketing agreement with Biomm SA for biosimilar Pegfilgrastim in Brazil. The Indian pharma company had earlier secured ... Read More
BioConnection to manufacture aseptic drug product for Nykode Therapeutics
BioConnection, a Dutch contract development manufacturing organization (CDMO), said that it has been selected by Nykode Therapeutics for manufacturing the aseptic drug product of its ... Read More
Ocuphire Pharma begins patient enrolment for Nyxol phase 3 trial
Ocuphire Pharma said that it has enrolled the first subjects in the MIRA-3 phase 3 clinical trial of Nyxol Eye Drops in the reversal of ... Read More
Ionis Pharmaceuticals begins donidalorsen phase 3 trial in hereditary angioedema
Ionis Pharmaceuticals, a US-based developer of RNA-targeted therapies, has launched the OASIS-HAE phase 3 clinical trial for donidalorsen (formerly IONIS-PKK-LRx) in patients having hereditary angioedema ... Read More
Sartorius to invest €270m to expand South Korea operations
Sartorius, a German pharma and lab equipment supplier, said that it is investing nearly €270 million through 2024 for expanding its operations in South Korea. ... Read More
FDA puts clinical hold on Selecta Biosciences SEL-302 phase 1/2 trial
Selecta Biosciences said that the US Food and Drug Administration (FDA) has imposed a clinical hold on its phase 1/2 clinical trial of SEL-302 gene ... Read More
Tonix Pharmaceuticals gets FDA clearance for TNX-1900 phase 2 trial in chronic migraineurs
Tonix Pharmaceuticals is set to launch a phase 2 clinical trial of TNX-1900 (intranasal potentiated oxytocin) in migraine patients after getting clearance from the US ... Read More
